Amylyx Pharmaceuticals (AMLX) Revenue & Revenue Breakdown
Amylyx Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$380.79M
Latest Revenue (Q)
$88.64M
Amylyx Pharmaceuticals Revenue by Period
Amylyx Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $380.79M | 1612.94% |
| 2022-12-31 | $22.23M | 7700.00% |
| 2021-12-31 | $285.00K | -56.15% |
| 2020-12-31 | $650.00K | -54.42% |
| 2019-12-31 | $1.43M | - |
Amylyx Pharmaceuticals generated $380.79M in revenue during NA 2023, up 1612.94% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Amylyx Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $88.64M | -18.26% |
| 2023-12-31 | $108.45M | 5.61% |
| 2023-09-30 | $102.69M | 4.56% |
| 2023-06-30 | $98.22M | 37.50% |
| 2023-03-31 | $71.43M | 226.38% |
| 2022-12-31 | $21.89M | 6243.48% |
| 2022-09-30 | $345.00K | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $285.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $350.00K | - |
Amylyx Pharmaceuticals generated $88.64M in revenue during Q1 2024, up -18.26% compared to the previous quarter, and up 405.04% compared to the same period a year ago.
Amylyx Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
AMLX Revenue FAQ
What is Amylyx Pharmaceuticals’s yearly revenue?
Amylyx Pharmaceuticals's yearly revenue for 2023 was $380.79M, representing an increase of 1612.94% compared to 2022. The company's yearly revenue for 2022 was $22.23M, representing an increase of 7700.00% compared to 2021. AMLX's yearly revenue for 2021 was $285K, representing a decrease of -56.15% compared to 2020.
What is Amylyx Pharmaceuticals’s quarterly revenue?
Amylyx Pharmaceuticals's quarterly revenue for Q1 2024 was $88.64M, a -18.26% decrease from the previous quarter (Q4 2023), and a 24.10% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $108.45M, a 5.61% increase from the previous quarter (Q3 2023), and a 395.54% increase year-over-year (Q4 2022). AMLX's quarterly revenue for Q3 2023 was $102.69M, a 4.56% increase from the previous quarter (Q2 2023), and a 29666.09% increase year-over-year (Q3 2022).
What is Amylyx Pharmaceuticals’s revenue growth rate?
Amylyx Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 133509.12%, and for the last 5 years (2019-2023) was 26603.09%.